GLP-1 drugs: what SoonerCare paid

Q: Does a paid prescription mean SoonerCare covers the drug?

No. A paid claim is a record of what happened in a past quarter. The rule that decides the next request is published separately, and a program can pay a claim in one quarter and exclude the product in the next. Where this site holds the published rule, the jurisdiction page for that program quotes it.

Q: Why do two brands of the same molecule show different numbers?

Because a payer answers each brand separately. Semaglutide is sold as Wegovy® for weight management and as Ozempic® for type 2 diabetes, and the two carry different licences. The table lists them as separate rows for that reason.

Q: What does a withheld figure mean?

The federal file suppresses a count too small to publish. Prescriptions were paid for and the number is not disclosed, so it is not a zero. Where part of a total was withheld, the figure shown is a floor.

SoonerCare shows a published payment figure for 7 of the 8 GLP-1 products this site tracks, in the latest federal quarter. This site has not yet read SoonerCare's own coverage rule, so the figures below are a payment history and nothing here tells you what the program will decide next.

By the Covered Weight editorial team · Updated Aug 8, 2026. Research and sourcing by Evan Reid.

What SoonerCare’s payment record shows

In 2026Q1, the product SoonerCare paid for most often was Ozempic®, at 5,036 prescriptions¹⁹ of the 9,371 to 9,551^{1,7,13,19,25,37,43} across all 8 products, or 54 percent of the published count.

SoonerCare itself reimbursed at least $9,429,993 for these products in the quarter, about $1,008 per prescription. Pharmacies were paid $9,782,702 in total, the difference being what other payers covered on the same claims. The costliest per prescription was Wegovy®, at about $1,313.

Every dollar figure on this page is what pharmacies were paid, before rebates. Manufacturers pay Medicaid programs rebates on these products, the federal file states that its amounts are not reduced by them, and CMS publishes no rebate figure per drug. So what SoonerCare finally kept is lower than what is shown here, by an amount this site cannot source.

Paid prescriptions per quarter, SoonerCare. The line is what the federal file published and the axis starts at zero. The shaded band is what the file leaves possible above it: each withheld product code stands for between one and ten prescriptions, so a wide band means a heavily suppressed record rather than a busy one. A gap in the line is a quarter the file did not report, never a zero.

What SoonerCare paid, product by product

For what each product is approved to treat, the split that decides most coverage questions, compare the products themselves.

Route, prescriptions, what SoonerCare paid and what all payers paid, for each GLP-1 product, 2026Q1
Product	Paid through	Prescriptions	Shareof this program	Program paidbefore rebates	All payers	Program per Rx
tirzepatideZepbound®	Fee-for-service	at least 64¹	<1%	$67,954	$68,090	$1,062
tirzepatideMounjaro®	Both2,736 managed care, 663 direct	3,399⁷	36%	$3,646,477	$3,808,202	$1,073
semaglutideWegovy®	Both204 managed care, 13 direct	at least 217¹³	2%	$284,959	$341,527	$1,313
semaglutideOzempic®	Both3,440 managed care, 1,596 direct	5,036¹⁹	54%	$5,003,407	$5,130,616	$994
semaglutideRybelsus®	Both152 managed care, 54 direct	206²⁵	2%	$205,538	$211,924	$998
liraglutideSaxenda®	Not published	No row	n/a	Not published	Not published	Not published
liraglutideVictoza®	Both122 managed care, 102 direct	224³⁷	2%	$141,836	$142,091	$633
liraglutideliraglutide (generic)	Both73 managed care, 132 direct	at least 205⁴³	2%	$79,821	$80,252	$389

SoonerCare publishes claims on both routes: paid directly by the program, and paid through the managed-care plans it contracts with. The figures above combine the two, so which one your own card names decides who answers a question about your prescription.

Across the 21 quarters on file, prescriptions for the products published at both ends of the series were higher in 2026Q1 than in 2021Q1: 5,466 against 1,350. Products whose count was withheld at either end are left out of that comparison, because a floor against a number cannot establish a direction.

Against enrollment, that is 10.5 to 10.7 prescriptions per thousand people enrolled in SoonerCare, on an average of 889,811 enrollees across the quarter. A raw count compares programs by how many people they cover; this is the figure that compares them by what they paid for.

2026Q1 covers January through March 2026, and it is the newest quarter CMS has published; that file was released on July 10, 2026. Every count here is a prescription filled rather than a person: one patient on a monthly product contributes several in a quarter, so nothing on this page says how many people take these products.

The file withheld 3 of the 168 product-quarters it holds a row for here, which is 2 percent. Each withheld cell records prescriptions that were paid for and a count that is not disclosed, so any total on this page that includes one is a floor rather than a sum.

Across every quarter on file, the federal record holds no row at all for Saxenda®. That is an absence in the file rather than a refusal by SoonerCare: no prescription was reported, and the reason is not published here.

Ozempic®, Rybelsus® and Victoza® carry a published count in every one of the 21 quarters, which is the closest this record comes to showing a product paid for routinely.

21 quarters, 2021Q1 to 2026Q1

One quarter cannot tell you whether SoonerCare pays for a product routinely or barely at all, and a single withheld cell reads as an absence when it is not.

Show what SoonerCare paid for each product, quarter by quarter

Prescriptions SoonerCare paid for, by product and quarter, 2021Q1 to 2026Q1
Product	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1
tirzepatideZepbound®	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter³No row	no row published paid prescriptions in the quarter (2024Q2)the dataset publishes no row for this product, state and quarter³No row	no row published paid prescriptions in the quarter (2024Q3)the dataset publishes no row for this product, state and quarter³No row	no row published paid prescriptions in the quarter (2024Q4)the dataset publishes no row for this product, state and quarter³No row	no row published paid prescriptions in the quarter (2025Q1)the dataset publishes no row for this product, state and quarter²No row	no row published paid prescriptions in the quarter (2025Q2)the dataset publishes no row for this product, state and quarter²No row	no row published paid prescriptions in the quarter (2025Q3)the dataset publishes no row for this product, state and quarter²No row	withheld as a small cell paid prescriptions in the quarter (2025Q4)every reporting cell was withheld, so nothing is observable²Withheld1 of 1 product codes withheld	at least 64 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld¹At least$67,954 paid
tirzepatideMounjaro®range 1,028 to 3,720, down 321 on the quarter before	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter¹¹No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter¹¹No row	at least 67 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld¹¹At least$63,574 paid	at least 552 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld¹¹At least$508,825 paid	1,138 paid prescriptions in the quarter (2023Q1)¹⁰Count$1,099,403 paid	1,334 paid prescriptions in the quarter (2023Q2)¹⁰Count$1,300,525 paid	1,375 paid prescriptions in the quarter (2023Q3)¹⁰Count$1,345,017 paid	1,253 paid prescriptions in the quarter (2023Q4)¹⁰Count$1,215,468 paid	1,028 paid prescriptions in the quarter (2024Q1)⁹Count$1,035,776 paid	2,240 paid prescriptions in the quarter (2024Q2)⁹Count$2,309,529 paid	2,571 paid prescriptions in the quarter (2024Q3)⁹Count$2,655,451 paid	2,858 paid prescriptions in the quarter (2024Q4)⁹Count$2,947,956 paid	3,099 paid prescriptions in the quarter (2025Q1)⁸Count$3,235,281 paid	3,509 paid prescriptions in the quarter (2025Q2)⁸Count$3,668,035 paid	3,595 paid prescriptions in the quarter (2025Q3)⁸Count$3,763,094 paid	3,720 paid prescriptions in the quarter (2025Q4)⁸Count$3,899,279 paid	3,399 paid prescriptions in the quarter (2026Q1)⁷Count$3,646,477 paid
semaglutideWegovy®	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter¹⁷No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter¹⁷No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter¹⁷No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter¹⁷No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter¹⁶No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter¹⁶No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter¹⁶No row	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter¹⁶No row	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter¹⁵No row	no row published paid prescriptions in the quarter (2024Q2)the dataset publishes no row for this product, state and quarter¹⁵No row	withheld as a small cell paid prescriptions in the quarter (2024Q3)every reporting cell was withheld, so nothing is observable¹⁵Withheld1 of 1 product codes withheld	at least 56 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld¹⁵At least$72,832 paid	at least 90 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld¹⁴At least$114,390 paid	at least 154 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld¹⁴At least$200,732 paid	at least 189 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld¹⁴At least$246,591 paid	at least 189 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld¹⁴At least$246,896 paid	at least 217 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld¹³At least$284,959 paid
semaglutideOzempic®range 215 to 5,540, down 476 on the quarter before	215 paid prescriptions in the quarter (2021Q1)²⁴Count$171,462 paid	283 paid prescriptions in the quarter (2021Q2)²⁴Count$230,646 paid	355 paid prescriptions in the quarter (2021Q3)²⁴Count$288,083 paid	at least 492 paid prescriptions in the quarter (2021Q4)a floor, because some reporting cells were withheld²⁴At least$403,028 paid	at least 702 paid prescriptions in the quarter (2022Q1)a floor, because some reporting cells were withheld²³At least$593,185 paid	1,051 paid prescriptions in the quarter (2022Q2)²³Count$891,253 paid	1,238 paid prescriptions in the quarter (2022Q3)²³Count$1,047,442 paid	1,467 paid prescriptions in the quarter (2022Q4)²³Count$1,235,683 paid	at least 1,812 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld²²At least$1,598,043 paid	1,888 paid prescriptions in the quarter (2023Q2)²²Count$1,684,276 paid	at least 2,079 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld²²At least$1,855,834 paid	2,161 paid prescriptions in the quarter (2023Q4)²²Count$1,944,219 paid	2,564 paid prescriptions in the quarter (2024Q1)²¹Count$2,379,131 paid	5,156 paid prescriptions in the quarter (2024Q2)²¹Count$4,823,935 paid	4,818 paid prescriptions in the quarter (2024Q3)²¹Count$4,514,794 paid	4,884 paid prescriptions in the quarter (2024Q4)²¹Count$4,582,338 paid	5,021 paid prescriptions in the quarter (2025Q1)²⁰Count$4,837,317 paid	5,540 paid prescriptions in the quarter (2025Q2)²⁰Count$5,350,840 paid	5,466 paid prescriptions in the quarter (2025Q3)²⁰Count$5,294,761 paid	5,512 paid prescriptions in the quarter (2025Q4)²⁰Count$5,349,597 paid	5,036 paid prescriptions in the quarter (2026Q1)¹⁹Count$5,003,407 paid
semaglutideRybelsus®range 61 to 214, up 2 on the quarter before	61 paid prescriptions in the quarter (2021Q1)³⁰Count$48,350 paid	73 paid prescriptions in the quarter (2021Q2)³⁰Count$57,910 paid	at least 61 paid prescriptions in the quarter (2021Q3)a floor, because some reporting cells were withheld³⁰At least$50,019 paid	at least 47 paid prescriptions in the quarter (2021Q4)a floor, because some reporting cells were withheld³⁰At least$38,139 paid	at least 47 paid prescriptions in the quarter (2022Q1)a floor, because some reporting cells were withheld²⁹At least$41,401 paid	at least 54 paid prescriptions in the quarter (2022Q2)a floor, because some reporting cells were withheld²⁹At least$46,823 paid	at least 55 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld²⁹At least$47,613 paid	at least 49 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld²⁹At least$41,911 paid	at least 59 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld²⁸At least$52,974 paid	at least 80 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld²⁸At least$71,721 paid	at least 102 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld²⁸At least$89,252 paid	105 paid prescriptions in the quarter (2023Q4)²⁸Count$92,352 paid	108 paid prescriptions in the quarter (2024Q1)²⁷Count$98,807 paid	at least 265 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld²⁷At least$245,497 paid	at least 205 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld²⁷At least$191,240 paid	at least 197 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld²⁷At least$184,514 paid	214 paid prescriptions in the quarter (2025Q1)²⁶Count$207,149 paid	196 paid prescriptions in the quarter (2025Q2)²⁶Count$188,836 paid	205 paid prescriptions in the quarter (2025Q3)²⁶Count$199,521 paid	204 paid prescriptions in the quarter (2025Q4)²⁶Count$200,690 paid	206 paid prescriptions in the quarter (2026Q1)²⁵Count$205,538 paid
liraglutideSaxenda®	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter³⁶No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter³⁶No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter³⁶No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter³⁶No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter³⁵No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter³⁵No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter³⁵No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter³⁵No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter³⁴No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter³⁴No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter³⁴No row	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter³⁴No row	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter³³No row	no row published paid prescriptions in the quarter (2024Q2)the dataset publishes no row for this product, state and quarter³³No row	no row published paid prescriptions in the quarter (2024Q3)the dataset publishes no row for this product, state and quarter³³No row	no row published paid prescriptions in the quarter (2024Q4)the dataset publishes no row for this product, state and quarter³³No row	no row published paid prescriptions in the quarter (2025Q1)the dataset publishes no row for this product, state and quarter³²No row	no row published paid prescriptions in the quarter (2025Q2)the dataset publishes no row for this product, state and quarter³²No row	no row published paid prescriptions in the quarter (2025Q3)the dataset publishes no row for this product, state and quarter³²No row	no row published paid prescriptions in the quarter (2025Q4)the dataset publishes no row for this product, state and quarter³²No row	no row published paid prescriptions in the quarter (2026Q1)the dataset publishes no row for this product, state and quarter³¹No row
liraglutideVictoza®range 100 to 1,292, down 15 on the quarter before	1,074 paid prescriptions in the quarter (2021Q1)⁴²Count$1,083,098 paid	1,120 paid prescriptions in the quarter (2021Q2)⁴²Count$1,149,041 paid	1,064 paid prescriptions in the quarter (2021Q3)⁴²Count$1,117,060 paid	1,100 paid prescriptions in the quarter (2021Q4)⁴²Count$1,168,284 paid	1,104 paid prescriptions in the quarter (2022Q1)⁴¹Count$1,205,655 paid	1,188 paid prescriptions in the quarter (2022Q2)⁴¹Count$1,318,749 paid	1,143 paid prescriptions in the quarter (2022Q3)⁴¹Count$1,282,536 paid	1,180 paid prescriptions in the quarter (2022Q4)⁴¹Count$1,296,366 paid	1,141 paid prescriptions in the quarter (2023Q1)⁴⁰Count$1,285,844 paid	1,292 paid prescriptions in the quarter (2023Q2)⁴⁰Count$1,444,687 paid	1,252 paid prescriptions in the quarter (2023Q3)⁴⁰Count$1,340,612 paid	1,106 paid prescriptions in the quarter (2023Q4)⁴⁰Count$1,216,247 paid	925 paid prescriptions in the quarter (2024Q1)³⁹Count$769,828 paid	1,112 paid prescriptions in the quarter (2024Q2)³⁹Count$859,315 paid	591 paid prescriptions in the quarter (2024Q3)³⁹Count$478,240 paid	627 paid prescriptions in the quarter (2024Q4)³⁹Count$504,186 paid	317 paid prescriptions in the quarter (2025Q1)³⁸Count$224,917 paid	100 paid prescriptions in the quarter (2025Q2)³⁸Count$69,194 paid	212 paid prescriptions in the quarter (2025Q3)³⁸Count$135,267 paid	239 paid prescriptions in the quarter (2025Q4)³⁸Count$160,347 paid	224 paid prescriptions in the quarter (2026Q1)³⁷Count$141,836 paid
liraglutideliraglutide (generic)range 132 to 369	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter⁴⁵No row	withheld as a small cell paid prescriptions in the quarter (2024Q2)every reporting cell was withheld, so nothing is observable⁴⁵Withheld2 of 2 product codes withheld	369 paid prescriptions in the quarter (2024Q3)⁴⁵Count$263,967 paid	132 paid prescriptions in the quarter (2024Q4)⁴⁵Count$89,691 paid	307 paid prescriptions in the quarter (2025Q1)⁴⁴Count$206,964 paid	at least 557 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld⁴⁴At least$300,315 paid	at least 350 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld⁴⁴At least$161,811 paid	at least 306 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld⁴⁴At least$132,962 paid	at least 205 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld⁴³At least$79,821 paid

What this page cannot tell you

Whether SoonerCare covers these products is decided by a document this site has not read yet: its preferred drug list and the prior-authorization criteria behind it. Until that is read and quoted, the payment history above is all this page asserts. Start from the notice or the drug list the program sent you, and check which document governs your plan first, because no state rule reaches a self-funded employer plan at all.

Open Oklahoma in the coverage explorer to see all 21 quarters of trend per product and switch jurisdictions without leaving the table.

Compare another jurisdiction from the national comparison.

Documents this page reads

48 documents, cited by number above. Each opens to its section, its effective date, and the quote the fact came from.

SDUD 2026, Zepbound, OK
State Drug Utilization Data 2026, Datastore query result, product_name like ZEPBOUND%, state OK, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "OK", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "ZEPBOUND ", "suppression_used": "false", "number_of_prescriptions": "43"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Zepbound, OK
State Drug Utilization Data 2025, Datastore query result, product_name like ZEPBOUND%, state OK, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "OK", "year": "2025", "quarter": "4", "utilization_type": "FFSU", "product_name": "ZEPBOUND ", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Zepbound, OK
State Drug Utilization Data 2024, Datastore query result, product_name like ZEPBOUND%, state OK, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "OK", "product_name": "product_name like ZEPBOUND%, state OK, 2024", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Zepbound, OK
State Drug Utilization Data 2023, Datastore query result, product_name like ZEPBOUND%, state OK, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "OK", "product_name": "product_name like ZEPBOUND%, state OK, 2023", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Zepbound, OK
State Drug Utilization Data 2022, Datastore query result, product_name like ZEPBOUND%, state OK, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "OK", "product_name": "product_name like ZEPBOUND%, state OK, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Zepbound, OK
State Drug Utilization Data 2021, Datastore query result, product_name like ZEPBOUND%, state OK, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "OK", "product_name": "product_name like ZEPBOUND%, state OK, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Mounjaro, OK
State Drug Utilization Data 2026, Datastore query result, product_name like MOUNJARO%, state OK, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "OK", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "565"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Mounjaro, OK
State Drug Utilization Data 2025, Datastore query result, product_name like MOUNJARO%, state OK, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "OK", "year": "2025", "quarter": "3", "utilization_type": "MCOU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "604"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Mounjaro, OK
State Drug Utilization Data 2024, Datastore query result, product_name like MOUNJARO%, state OK, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "OK", "year": "2024", "quarter": "2", "utilization_type": "MCOU", "product_name": "MOUNJARO 2", "suppression_used": "false", "number_of_prescriptions": "726"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Mounjaro, OK
State Drug Utilization Data 2023, Datastore query result, product_name like MOUNJARO%, state OK, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "OK", "year": "2023", "quarter": "1", "utilization_type": "FFSU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "457"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Mounjaro, OK
State Drug Utilization Data 2022, Datastore query result, product_name like MOUNJARO%, state OK, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "OK", "year": "2022", "quarter": "4", "utilization_type": "FFSU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "248"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Mounjaro, OK
State Drug Utilization Data 2021, Datastore query result, product_name like MOUNJARO%, state OK, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "OK", "product_name": "product_name like MOUNJARO%, state OK, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Wegovy, OK
State Drug Utilization Data 2026, Datastore query result, product_name like WEGOVY%, state OK, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "OK", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "WEGOVY 0.2", "suppression_used": "false", "number_of_prescriptions": "74"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Wegovy, OK
State Drug Utilization Data 2025, Datastore query result, product_name like WEGOVY%, state OK, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "OK", "year": "2025", "quarter": "3", "utilization_type": "MCOU", "product_name": "WEGOVY 0.2", "suppression_used": "false", "number_of_prescriptions": "62"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Wegovy, OK
State Drug Utilization Data 2024, Datastore query result, product_name like WEGOVY%, state OK, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "OK", "year": "2024", "quarter": "4", "utilization_type": "MCOU", "product_name": "WEGOVY 0.2", "suppression_used": "false", "number_of_prescriptions": "27"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Wegovy, OK
State Drug Utilization Data 2023, Datastore query result, product_name like WEGOVY%, state OK, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "OK", "product_name": "product_name like WEGOVY%, state OK, 2023", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Wegovy, OK
State Drug Utilization Data 2022, Datastore query result, product_name like WEGOVY%, state OK, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "OK", "product_name": "product_name like WEGOVY%, state OK, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Wegovy, OK
State Drug Utilization Data 2021, Datastore query result, product_name like WEGOVY%, state OK, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "OK", "product_name": "product_name like WEGOVY%, state OK, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Ozempic, OK
State Drug Utilization Data 2026, Datastore query result, product_name like OZEMPIC%, state OK, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "OK", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "OZEMPIC 2M", "suppression_used": "false", "number_of_prescriptions": "1393"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Ozempic, OK
State Drug Utilization Data 2025, Datastore query result, product_name like OZEMPIC%, state OK, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "OK", "year": "2025", "quarter": "4", "utilization_type": "MCOU", "product_name": "OZEMPIC 2M", "suppression_used": "false", "number_of_prescriptions": "1540"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Ozempic, OK
State Drug Utilization Data 2024, Datastore query result, product_name like OZEMPIC%, state OK, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "OK", "year": "2024", "quarter": "2", "utilization_type": "MCOU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "1749"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Ozempic, OK
State Drug Utilization Data 2023, Datastore query result, product_name like OZEMPIC%, state OK, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "OK", "year": "2023", "quarter": "4", "utilization_type": "FFSU", "product_name": "OZEMPIC 1M", "suppression_used": "false", "number_of_prescriptions": "834"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Ozempic, OK
State Drug Utilization Data 2022, Datastore query result, product_name like OZEMPIC%, state OK, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "OK", "year": "2022", "quarter": "4", "utilization_type": "FFSU", "product_name": "OZEMPIC 1M", "suppression_used": "false", "number_of_prescriptions": "611"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Ozempic, OK
State Drug Utilization Data 2021, Datastore query result, product_name like OZEMPIC%, state OK, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "OK", "year": "2021", "quarter": "4", "utilization_type": "FFSU", "product_name": "OZEMPIC 1M", "suppression_used": "false", "number_of_prescriptions": "258"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Rybelsus, OK
State Drug Utilization Data 2026, Datastore query result, product_name like RYBELSUS%, state OK, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "OK", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "RYBELSUS 1", "suppression_used": "false", "number_of_prescriptions": "54"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Rybelsus, OK
State Drug Utilization Data 2025, Datastore query result, product_name like RYBELSUS%, state OK, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "OK", "year": "2025", "quarter": "1", "utilization_type": "MCOU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "63"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Rybelsus, OK
State Drug Utilization Data 2024, Datastore query result, product_name like RYBELSUS%, state OK, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "OK", "year": "2024", "quarter": "2", "utilization_type": "MCOU", "product_name": "RYBELSUS 3", "suppression_used": "false", "number_of_prescriptions": "103"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Rybelsus, OK
State Drug Utilization Data 2023, Datastore query result, product_name like RYBELSUS%, state OK, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "OK", "year": "2023", "quarter": "4", "utilization_type": "FFSU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "51"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Rybelsus, OK
State Drug Utilization Data 2022, Datastore query result, product_name like RYBELSUS%, state OK, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "OK", "year": "2022", "quarter": "2", "utilization_type": "FFSU", "product_name": "RYBELSUS 1", "suppression_used": "false", "number_of_prescriptions": "33"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Rybelsus, OK
State Drug Utilization Data 2021, Datastore query result, product_name like RYBELSUS%, state OK, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "OK", "year": "2021", "quarter": "2", "utilization_type": "FFSU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "41"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Saxenda, OK
State Drug Utilization Data 2026, Datastore query result, product_name like SAXENDA%, state OK, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "OK", "product_name": "product_name like SAXENDA%, state OK, 2026", "result_count": 0}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Saxenda, OK
State Drug Utilization Data 2025, Datastore query result, product_name like SAXENDA%, state OK, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "OK", "product_name": "product_name like SAXENDA%, state OK, 2025", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Saxenda, OK
State Drug Utilization Data 2024, Datastore query result, product_name like SAXENDA%, state OK, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "OK", "product_name": "product_name like SAXENDA%, state OK, 2024", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Saxenda, OK
State Drug Utilization Data 2023, Datastore query result, product_name like SAXENDA%, state OK, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "OK", "product_name": "product_name like SAXENDA%, state OK, 2023", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Saxenda, OK
State Drug Utilization Data 2022, Datastore query result, product_name like SAXENDA%, state OK, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "OK", "product_name": "product_name like SAXENDA%, state OK, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Saxenda, OK
State Drug Utilization Data 2021, Datastore query result, product_name like SAXENDA%, state OK, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "OK", "product_name": "product_name like SAXENDA%, state OK, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Victoza, OK
State Drug Utilization Data 2026, Datastore query result, product_name like VICTOZA%, state OK, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "OK", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "72"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Victoza, OK
State Drug Utilization Data 2025, Datastore query result, product_name like VICTOZA%, state OK, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "OK", "year": "2025", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "121"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Victoza, OK
State Drug Utilization Data 2024, Datastore query result, product_name like VICTOZA%, state OK, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "OK", "year": "2024", "quarter": "1", "utilization_type": "FFSU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "628"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Victoza, OK
State Drug Utilization Data 2023, Datastore query result, product_name like VICTOZA%, state OK, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "OK", "year": "2023", "quarter": "2", "utilization_type": "FFSU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "871"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Victoza, OK
State Drug Utilization Data 2022, Datastore query result, product_name like VICTOZA%, state OK, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "OK", "year": "2022", "quarter": "4", "utilization_type": "FFSU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "851"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Victoza, OK
State Drug Utilization Data 2021, Datastore query result, product_name like VICTOZA%, state OK, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "OK", "year": "2021", "quarter": "4", "utilization_type": "FFSU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "792"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Liraglutid, OK
State Drug Utilization Data 2026, Datastore query result, product_name like LIRAGLUTID%, state OK, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "OK", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "91"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Liraglutid, OK
State Drug Utilization Data 2025, Datastore query result, product_name like LIRAGLUTID%, state OK, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "OK", "year": "2025", "quarter": "2", "utilization_type": "FFSU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "131"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Liraglutid, OK
State Drug Utilization Data 2024, Datastore query result, product_name like LIRAGLUTID%, state OK, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "OK", "year": "2024", "quarter": "3", "utilization_type": "MCOU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "134"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Liraglutid, OK
State Drug Utilization Data 2023, Datastore query result, product_name like LIRAGLUTID%, state OK, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "OK", "product_name": "product_name like LIRAGLUTID%, state OK, 2023", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Liraglutid, OK
State Drug Utilization Data 2022, Datastore query result, product_name like LIRAGLUTID%, state OK, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "OK", "product_name": "product_name like LIRAGLUTID%, state OK, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Liraglutid, OK
State Drug Utilization Data 2021, Datastore query result, product_name like LIRAGLUTID%, state OK, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "OK", "product_name": "product_name like LIRAGLUTID%, state OK, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026

How the quoted row is presented, for 31 of these documents

One row of the API response for the query in url, with the fields that do not bear on this fact omitted and the rest left exactly as the API returns them, including the trailing spaces the ten-character product_name field pads with. Open the url to re-read the whole result set and re-sum it.

How the quoted row is presented, for 17 of these documents

The query in url returns an empty result set, which is the evidence. An absence cannot be quoted, so the record states the query and its count instead.

Common questions

Does a paid prescription mean SoonerCare covers the drug?

No. A paid claim is a record of what happened in a past quarter. The rule that decides the next request is published separately, and a program can pay a claim in one quarter and exclude the product in the next. Where this site holds the published rule, the jurisdiction page for that program quotes it.

Why do two brands of the same molecule show different numbers?

Because a payer answers each brand separately. Semaglutide is sold as Wegovy® for weight management and as Ozempic® for type 2 diabetes, and the two carry different licences. The table lists them as separate rows for that reason.

What does a withheld figure mean?

The federal file suppresses a count too small to publish. Prescriptions were paid for and the number is not disclosed, so it is not a zero. Where part of a total was withheld, the figure shown is a floor.